Medtronic Neuromodulation recalls A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software…
- Recall date
- December 3, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1043-2026
- FDA classification
- Class II
- Brand / firm
- Medtronic Neuromodulation
- Sold / distributed
- Worldwide - US Nationwide distribution.
Why it was recalled
Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).
Get recall alerts
Free email alert whenever Medtronic Neuromodulation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Medtronic Neuromodulation